UroLift Procedure: Prostate Urethral Lift for BPH – Complete Guide
- What is UroLift?
- How does UroLift work?
- Who is a good candidate for UroLift?
- The UroLift procedure – what to expect
- Recovery and downtime
- Effectiveness – symptom improvement and durability
- Side effects – preserves ejaculation
- UroLift vs. TURP vs. Rezum
- Cost and insurance coverage
- Interactive FAQ – 9 questions about UroLift
What is UroLift?
UroLift is a minimally invasive treatment for benign prostatic hyperplasia (BPH) that uses small permanent implants to hold the prostate lobes open, relieving urethral obstruction. Unlike other treatments, UroLift does not cut, heat, or remove prostate tissue.
The UroLift system was FDA-approved in 2013 and has been performed on over 400,000 men worldwide. It is the only BPH treatment that preserves ejaculatory function in over 95% of men.
How does UroLift work?
UroLift works like a "curtain tie-back" for the prostate:
The mechanism:
- Small implants (made of nitinol – a nickel-titanium alloy) are placed through the urethra
- Each implant consists of a stainless steel tab (on the outside of the prostate) connected by a suture to a nitinol capsule (on the inside of the urethra)
- When deployed, the implant pulls the prostate lobe away from the urethra and anchors it to the prostate capsule
- This opens the urethral channel without removing any tissue
- Typically 2-6 implants are placed depending on prostate size and anatomy
Key advantages:
- No tissue destruction (no heat, steam, or cutting)
- No implant left behind? Actually implants are permanent but well-tolerated
- Preserves the urethral lining and ejaculatory ducts
- Immediate opening of the urethra
Who is a good candidate for UroLift?
Ideal candidates for UroLift meet the following criteria:
- Prostate size: 30-80 mL (small to moderately enlarged)
- Symptoms: Moderate to severe BPH symptoms (IPSS ≥12)
- Medication failure: Poor response or intolerance to BPH medications
- Preserving ejaculation is important (retrograde ejaculation rate <2%)
- No large median lobe (UroLift less effective if median lobe is significantly enlarged)
Who is NOT a good candidate?
- Very large prostates >80 mL (less effective; consider Rezum, Aquablation, or TURP)
- Large median lobe (obstructing the bladder neck)
- Active urinary tract infection
- Bladder stones or large bladder diverticula
- Urethral stricture (narrowing) that prevents scope passage
- Known prostate cancer (requires different treatment)
The UroLift procedure – what to expect
Before the procedure:
- Blood thinners can often be continued (UroLift is low-bleeding risk)
- Antibiotics may be prescribed to prevent infection
- No special bowel preparation or fasting required
Day of procedure:
- Performed in a urology office or outpatient centre
- Anaesthesia: Local anaesthesia (lidocaine gel in urethra) plus oral sedation. General anaesthesia is not required.
- Position: Lying on your back with legs in stirrups
- Duration: 15-30 minutes
Step-by-step:
- A small scope (cystoscope) with a special delivery device is inserted into the urethra
- The UroLift delivery device is positioned next to an obstructing prostate lobe
- A small needle deploys the implant through the prostate lobe
- The implant anchors the lobe to the prostate capsule, pulling it open
- The process is repeated for each lobe (typically 2-6 implants)
- The scope is removed – no incisions or stitches
Recovery and downtime
Immediate post-procedure (first 24-48 hours):
- Catheter: Most men do NOT need a catheter (only 5-10% require temporary catheter)
- Burning with urination (dysuria): Common – lasts 1-2 weeks
- Blood in urine (hematuria): Common – lasts 3-7 days
- Pelvic discomfort or pressure: Mild, resolves in days
Return to activities:
- Desk work: 1-3 days
- Physical labour: 1-2 weeks
- Exercise (light): 1 week
- Sexual activity: 2-3 weeks (after discomfort resolves)
Symptom improvement timeline:
- Days 1-3: Temporary worsening due to swelling (normal)
- Week 1-2: Initial symptom improvement begins
- Week 4: Significant improvement (most men notice benefit)
- Month 3: Maximum benefit achieved
Effectiveness – symptom improvement and durability
Clinical studies demonstrate excellent outcomes with UroLift:
5-year clinical trial results (LIFT study):
- IPSS reduction: 40-50% (e.g., 22 → 12)
- Peak flow rate (Qmax) increase: 40-60% (e.g., 9 → 13-14 mL/s)
- Quality of life improvement: Significant (QoL score improved by 50%)
- Durability: 5-year data shows sustained improvement with low re-treatment rates (10-15% needed repeat procedure)
Patient satisfaction:
- 85-90% of men report being satisfied or very satisfied at 5 years
- 92% would recommend UroLift to a friend
- Ejaculation preservation: 95% of men maintain normal ejaculation
Side effects – preserves ejaculation
UroLift has the most favourable side effect profile among BPH procedures, especially regarding sexual function.
Common side effects (occur in >10%):
- Hematuria (blood in urine): 50-60% – mild, resolves in 3-7 days
- Dysuria (painful urination): 40-50% – mild, lasts 1-2 weeks
- Pelvic pain/pressure: 20-30% – mild, resolves in days
- Urinary urgency/frequency: 20-30% – temporary
Sexual side effects (very low):
- Retrograde ejaculation: <2% (best among all BPH procedures)
- Erectile dysfunction: <1% (rare)
- Decreased ejaculate volume: <1%
Less common side effects (2-10%):
- Urinary retention requiring catheter: 5-10% – usually resolves in 1-3 days
- Urinary tract infection: 2-5% – treated with antibiotics
Rare side effects (<2%):
- Urinary incontinence (very rare – <1%)
- Implant erosion (extremely rare – <0.5%)
UroLift vs. TURP vs. Rezum
| Feature | UroLift | Rezum | TURP |
|---|---|---|---|
| Anaesthesia | Local + sedation | Local + sedation | General or spinal |
| Procedure time | 15-30 min | 5-10 min | 30-60 min |
| Hospital stay | None | None | 1-2 days |
| Catheter required | 5-10% | 10-15% | 1-2 days (100%) |
| Return to work | 1-3 days | 1-3 days | 2-4 weeks |
| IPSS reduction | 40-50% | 50-60% | 60-70% |
| Prostate size range | 30-80 mL | 30-80 mL | 30-100+ mL |
| Retrograde ejaculation | <2% | 20-30% | 70-80% |
| Erectile dysfunction risk | <1% | <2% | 5-10% |
Cost and insurance coverage
- Medicare: Covers UroLift for eligible patients (must meet criteria)
- Private insurance: Most major insurers cover UroLift (coverage varies – check with your plan)
- Out-of-pocket cost: $2,500-$6,000 depending on insurance, deductibles, and number of implants
- Compared to TURP: UroLift is often less expensive when factoring in hospital stay and anaesthesia costs
Interactive FAQ – UroLift procedure
Most men report mild discomfort, not severe pain. Local anaesthesia and sedation keep you comfortable. You may feel pressure or brief pinching during implant placement.
The procedure itself takes 15-30 minutes. Total time in the office (preparation, procedure, recovery) is about 1-2 hours.
Very rarely – less than 2% of men experience retrograde ejaculation. This is the lowest rate of any surgical BPH treatment.
No – less than 1% of men report new erectile dysfunction. UroLift is considered very safe for erectile function.
5-year studies show 85-90% satisfaction rate. IPSS improves by 40-50%, and peak flow improves by 40-60%.
Best for prostates 30-80 mL. For larger prostates (>80 mL), Rezum or Aquablation may be more effective.
Yes – if symptoms return after several years, UroLift can be repeated. Re-treatment rate at 5 years is 10-15%.
Medicare and most private insurers cover UroLift. Check with your provider for specific coverage details.
Initial improvement in 1-2 weeks. Maximum benefit at 3 months. There may be temporary worsening in the first few days due to swelling.
Disclaimer: This information is for educational purposes. UroLift is a medical procedure with risks and benefits. Discuss with a urologist at Vivekananda Hospital to determine if UroLift is right for you.